Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from AI Technology Group ( (AIPG) ) is now available.
On December 15, 2025, AI Technology Group Inc., a company engaged in advanced technological ventures, executed a Share Exchange Agreement to acquire AVM Biotechnology Inc. and its operations. This strategic acquisition involves Biomed 360 Solutions Corp., the sole shareholder of AVM, exchanging 100% of AVM’s shares for 100 shares of AI Technology Group, making AVM a wholly-owned subsidiary of the Corporation. The transaction is structured as a tax-free reorganization under U.S. tax regulations. The acquisition also includes AVM’s convertible debentures valued at $1,125,000, convertible into 584,800 common shares of AI Technology Group. The acquired shares were exempt from registration under securities laws, signaling a streamlined approach to integrating AVM’s assets and liabilities into the Corporation. This move positions AI Technology Group to potentially broaden its market presence and strengthen its industry positioning through AVM’s resources and biotechnology expertise.
More about AI Technology Group
Average Trading Volume: 332
Technical Sentiment Signal: Buy
Current Market Cap: $4.01M
For an in-depth examination of AIPG stock, go to TipRanks’ Overview page.

